Here’s Why Jounce Therapeutics, Inc. (NASDAQ:JNCE) Dropped -6.4%

For its latest trading sesion, Jounce Therapeutics, Inc. (NASDAQ:JNCE) dropped by -6.4% – here is what that looked like (as of 2020-01-06):

What is the cause of all this?? To have a greater insight of what is happening, it is helpful to analyze some technical indicators. The most important ones are as follows:

A Money Flow Index (MFI) of 100.0, a Relative Strength Index (RSI) of 50.0, a True Strength Index (TSI) of 100.0, a Moving Average Convergence Divergence (MACD) of 0.005, an Average Directional Movement Index (ADX) of unknown, an Average True Range (ATR) of 0.207, an Accumulation/Distribution Index (ADI) of 0.207, an On-Balance Volume (OBV) of 56.637, and a Chaiikin Money Flow (CMF) of 8.7. 2.632

Now let’s take all these indicators into account. According to Trading View, we can conclude the following:

So there you have it – our analysis of Jounce Therapeutics, Inc. (NASDAQ:JNCE). And finally, make sure to DO YOUR OWN RESEARCH! Take the above with a grain of salt, and do your own research.